Skip To Main Content
Abigail Powell on Muck Rack

Abigail Powell

Arizona
As seen in: Color Research & Application, Nature, ABC News (Australia), SAGE Publishing, The Conversation, ACS Publications, Science Magazine, Royal Society of Chemistry, BioRxiv, Emerald Publishing and

Get in touch with Abigail

Contact Abigail, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Abigail Powell’s Journalist Portfolio

See all →
Chief of Strategy for Content and Media Chase Franklin International

Chief of Strategy for Content and Media Chase Franklin International

Chase Franklin Chase Franklin is Chief of Strategy for Content and Media at Amdocs, the leader in providin…

View article →
OIL FIRED BOILERS

OIL FIRED BOILERS

Our selection of oil fired boilers is part of IB&M’s commitment to being the one-stop supplier of all your bo…

View article →
Johnstone Boiler Area Company Manufacturer

Johnstone Boiler Area Company Manufacturer

Johnston Boiler Company manufactures the worlds largest Scotch marine firetube boiler. Johnston pioneered the…

View article →
Boiler Supply Who We Are

Boiler Supply Who We Are

Launching operations in Nashville during 1942, Boiler Supply Company, Inc.’s founder Wallace E. Lunn, Sr., P.…

View article →
Westward : PRESS

Westward : PRESS

Westward has been featured in publications and broadcasts locally and around the world. highlights include: G…

View article →
Bradley John Haddy Attorney At Law: Eagan DUI DWI Lawyer

Bradley John Haddy Attorney At Law: Eagan DUI DWI Lawyer

If you are charged with a DUI/DWI in Minnesota, it is crucial that you speak with a driving under the influen…

View article →

Articles

A stabilized MERS-CoV spike ferritin nanoparticle vaccine elicits robust and protective neutralizing antibody responses - Nature Communications

|
By Abigail Powell, Hannah Caruso, Soyoon Park, Brian Ferrer, Daniel J. Stieh, Adam Weiss, David M. Belnap, Kaitlin R Sprouse, David Veesler, Richard Bowen, Michael Kay Verified
| Nature Verified
Abstract Middle East respiratory syndrome coronavirus (MERS-CoV) was identified as a human pathogen in 2012 and causes ongoing sporadic infections and outbreak clusters. Despite case fatality rates (CFRs) of over 30% and considerable pandemic potential, a safe and efficacious vaccine has not been developed. Here we report the design, characterization, and preclinical evaluation of MERS-CoV antigens.
Open in Who Shared Issue with article?

Structure and immunogenicity of an engineered soluble prefusion-stabilized EBV gB antigen - Nature Communications

|
By Ryan S. McCool, Abigail Powell, Daniel J. Stieh, Chia-Wei Chou, Soyoon Park, Patrick Byrne
| Nature Verified
Abstract Epstein-Barr virus (EBV), the causative agent of mononucleosis, is linked to over 140,000 annual cancer-related deaths globally and increases the risk of multiple sclerosis by up to 32-fold. As a herpesvirus, EBV establishes lifelong infection, and over 90% of U.S. adults are EBV-seropositive. Despite its significant disease burden, no approved EBV vaccines or therapeutics exist.
Open in Who Shared Issue with article?

Design, Structure, and Immunogenicity of a Soluble Prefusion-stabilized EBV gB Antigen

|
By Patrick Byrne, Cory M. Acreman, Abigail Powell, Ryan S. McCool
| BioRxiv
Abstract Epstein-Barr virus (EBV), the causative agent of mononucleosis, is linked to over 140,000 annual cancer-related deaths globally and increases the risk of multiple sclerosis by up to 32-fold. As a herpesvirus, EBV establishes lifelong infection, and over 90% of U.S. adults are EBV-seropositive. Despite its significant disease burden, no approved EBV vaccines or therapeutics exist.
Open in Who Shared Issue with article?
See all 19 licensed articles (20 Total)